 | • レポートコード：GIR-2104Z06883 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヘパリン（低分子量）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヘパリン（低分子量）の種類別市場規模（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）、用途別市場規模（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヘパリン（低分子量）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutical、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン ・用途別分析2016年-2026年：静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他 ・ヘパリン（低分子量）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヘパリン（低分子量）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヘパリン（低分子量）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヘパリン（低分子量）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヘパリン（低分子量）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Heparin (Low Molecular Weight) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Heparin (Low Molecular Weight) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Heparin (Low Molecular Weight) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Heparin (Low Molecular Weight) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market segment by Application can be divided into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
The key market players for global Heparin (Low Molecular Weight) market are listed below:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Heparin (Low Molecular Weight) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Heparin (Low Molecular Weight) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Market Analysis by Application
1.3.1 Overview: Global Heparin (Low Molecular Weight) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Global Heparin (Low Molecular Weight) Market Size & Forecast
1.4.1 Global Heparin (Low Molecular Weight) Sales in Value (2016-2026))
1.4.2 Global Heparin (Low Molecular Weight) Sales in Volume (2016-2026)
1.4.3 Global Heparin (Low Molecular Weight) Price by Type (2016-2026) & (US$/Ton)
1.5 Global Heparin (Low Molecular Weight) Production Capacity Analysis
1.5.1 Global Heparin (Low Molecular Weight) Total Production Capacity (2016-2026)
1.5.2 Global Heparin (Low Molecular Weight) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Heparin (Low Molecular Weight) Market Drivers
1.6.2 Heparin (Low Molecular Weight) Market Restraints
1.6.3 Heparin (Low Molecular Weight) Trends Analysis
2 Manufacturers Profiles
2.1 Aspen
2.1.1 Aspen Details
2.1.2 Aspen Major Business
2.1.3 Aspen Heparin (Low Molecular Weight) Product and Services
2.1.4 Aspen Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi-aventis
2.2.1 Sanofi-aventis Details
2.2.2 Sanofi-aventis Major Business
2.2.3 Sanofi-aventis Heparin (Low Molecular Weight) Product and Services
2.2.4 Sanofi-aventis Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Heparin (Low Molecular Weight) Product and Services
2.3.4 Pfizer Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Opocrin
2.4.1 Opocrin Details
2.4.2 Opocrin Major Business
2.4.3 Opocrin Heparin (Low Molecular Weight) Product and Services
2.4.4 Opocrin Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CSBIO
2.5.1 CSBIO Details
2.5.2 CSBIO Major Business
2.5.3 CSBIO Heparin (Low Molecular Weight) Product and Services
2.5.4 CSBIO Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Dongying Tiandong Pharmaceutical
2.6.1 Dongying Tiandong Pharmaceutical Details
2.6.2 Dongying Tiandong Pharmaceutical Major Business
2.6.3 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product and Services
2.6.4 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Changzhou Qianhong Bio-pharma
2.7.1 Changzhou Qianhong Bio-pharma Details
2.7.2 Changzhou Qianhong Bio-pharma Major Business
2.7.3 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product and Services
2.7.4 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Techdow
2.8.1 Techdow Details
2.8.2 Techdow Major Business
2.8.3 Techdow Heparin (Low Molecular Weight) Product and Services
2.8.4 Techdow Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Yantai Dongcheng Pharmaceutical Group
2.9.1 Yantai Dongcheng Pharmaceutical Group Details
2.9.2 Yantai Dongcheng Pharmaceutical Group Major Business
2.9.3 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product and Services
2.9.4 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Heparin (Low Molecular Weight) Sales by Manufacturer
3.1 Global Heparin (Low Molecular Weight) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Heparin (Low Molecular Weight) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Heparin (Low Molecular Weight)
3.4 Market Concentration Rate
3.4.1 Top 3 Heparin (Low Molecular Weight) Manufacturer Market Share
3.4.2 Top 6 Heparin (Low Molecular Weight) Manufacturer Market Share
3.5 Global Heparin (Low Molecular Weight) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Heparin (Low Molecular Weight) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Heparin (Low Molecular Weight) Market Size by Region
4.1.1 Global Heparin (Low Molecular Weight) Sales in Volume by Region (2016-2026)
4.1.2 Global Heparin (Low Molecular Weight) Revenue by Region (2016-2026)
4.2 North America Heparin (Low Molecular Weight) Revenue (2016-2026)
4.3 Europe Heparin (Low Molecular Weight) Revenue (2016-2026)
4.4 Asia-Pacific Heparin (Low Molecular Weight) Revenue (2016-2026)
4.5 South America Heparin (Low Molecular Weight) Revenue (2016-2026)
4.6 Middle East and Africa Heparin (Low Molecular Weight) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Heparin (Low Molecular Weight) Sales in Volume by Type (2016-2026)
5.2 Global Heparin (Low Molecular Weight) Revenue by Type (2016-2026)
5.3 Global Heparin (Low Molecular Weight) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Heparin (Low Molecular Weight) Sales in Volume by Application (2016-2026)
6.2 Global Heparin (Low Molecular Weight) Revenue by Application (2016-2026)
6.3 Global Heparin (Low Molecular Weight) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Heparin (Low Molecular Weight) Sales by Type (2016-2026)
7.2 North America Heparin (Low Molecular Weight) Sales by Application (2016-2026)
7.3 North America Heparin (Low Molecular Weight) Market Size by Country
7.3.1 North America Heparin (Low Molecular Weight) Sales in Volume by Country (2016-2026)
7.3.2 North America Heparin (Low Molecular Weight) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Heparin (Low Molecular Weight) Sales by Type (2016-2026)
8.2 Europe Heparin (Low Molecular Weight) Sales by Application (2016-2026)
8.3 Europe Heparin (Low Molecular Weight) Market Size by Country
8.3.1 Europe Heparin (Low Molecular Weight) Sales in Volume by Country (2016-2026)
8.3.2 Europe Heparin (Low Molecular Weight) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Heparin (Low Molecular Weight) Sales by Type (2016-2026)
9.2 Asia-Pacific Heparin (Low Molecular Weight) Sales by Application (2016-2026)
9.3 Asia-Pacific Heparin (Low Molecular Weight) Market Size by Region
9.3.1 Asia-Pacific Heparin (Low Molecular Weight) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Heparin (Low Molecular Weight) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Heparin (Low Molecular Weight) Sales by Type (2016-2026)
10.2 South America Heparin (Low Molecular Weight) Sales by Application (2016-2026)
10.3 South America Heparin (Low Molecular Weight) Market Size by Country
10.3.1 South America Heparin (Low Molecular Weight) Sales in Volume by Country (2016-2026)
10.3.2 South America Heparin (Low Molecular Weight) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Heparin (Low Molecular Weight) Sales by Type (2016-2026)
11.2 Middle East & Africa Heparin (Low Molecular Weight) Sales by Application (2016-2026)
11.3 Middle East & Africa Heparin (Low Molecular Weight) Market Size by Country
11.3.1 Middle East & Africa Heparin (Low Molecular Weight) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Heparin (Low Molecular Weight) Typical Distributors
12.3 Heparin (Low Molecular Weight) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Heparin (Low Molecular Weight) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Heparin (Low Molecular Weight) Revenue by Application, (USD Million), 2021-2026
Table 3. Aspen Basic Information, Manufacturing Base and Competitors
Table 4. Aspen Major Business
Table 5. Aspen Heparin (Low Molecular Weight) Product and Services
Table 6. Aspen Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi-aventis Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi-aventis Major Business
Table 9. Sanofi-aventis Heparin (Low Molecular Weight) Product and Services
Table 10. Sanofi-aventis Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Heparin (Low Molecular Weight) Product and Services
Table 14. Pfizer Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Opocrin Basic Information, Manufacturing Base and Competitors
Table 16. Opocrin Major Business
Table 17. Opocrin Heparin (Low Molecular Weight) Product and Services
Table 18. Opocrin Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CSBIO Basic Information, Manufacturing Base and Competitors
Table 20. CSBIO Major Business
Table 21. CSBIO Heparin (Low Molecular Weight) Product and Services
Table 22. CSBIO Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Dongying Tiandong Pharmaceutical Major Business
Table 25. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product and Services
Table 26. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
Table 28. Changzhou Qianhong Bio-pharma Major Business
Table 29. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product and Services
Table 30. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Techdow Basic Information, Manufacturing Base and Competitors
Table 32. Techdow Major Business
Table 33. Techdow Heparin (Low Molecular Weight) Product and Services
Table 34. Techdow Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 36. Yantai Dongcheng Pharmaceutical Group Major Business
Table 37. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product and Services
Table 38. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Heparin (Low Molecular Weight) Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 40. Global Heparin (Low Molecular Weight) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Heparin (Low Molecular Weight), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Heparin (Low Molecular Weight) Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 43. Head Office and Heparin (Low Molecular Weight) Production Site of Key Manufacturer
Table 44. Global Heparin (Low Molecular Weight) Sales by Region (2016-2021e) & (Kiloton)
Table 45. Global Heparin (Low Molecular Weight) Sales by Region (2021-2026) & (Kiloton)
Table 46. Global Heparin (Low Molecular Weight) Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Heparin (Low Molecular Weight) Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 49. Global Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 50. Global Heparin (Low Molecular Weight) Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Heparin (Low Molecular Weight) Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Heparin (Low Molecular Weight) Price by Type (2016-2021e) & (US$/Ton)
Table 53. Global Heparin (Low Molecular Weight) Price by Type (2021-2026) & (US$/Ton)
Table 54. Global Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 55. Global Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 56. Global Heparin (Low Molecular Weight) Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Heparin (Low Molecular Weight) Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Heparin (Low Molecular Weight) Price by Application (2016-2021e) & (US$/Ton)
Table 59. Global Heparin (Low Molecular Weight) Price by Application (2021-2026) & (US$/Ton)
Table 60. North America Heparin (Low Molecular Weight) Sales by Country (2016-2021e) & (Kiloton)
Table 61. North America Heparin (Low Molecular Weight) Sales by Country (2021-2026) & (Kiloton)
Table 62. North America Heparin (Low Molecular Weight) Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Heparin (Low Molecular Weight) Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 65. North America Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 66. North America Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 67. North America Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 68. Europe Heparin (Low Molecular Weight) Sales by Country (2016-2021e) & (Kiloton)
Table 69. Europe Heparin (Low Molecular Weight) Sales by Country (2021-2026) & (Kiloton)
Table 70. Europe Heparin (Low Molecular Weight) Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Heparin (Low Molecular Weight) Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 73. Europe Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 74. Europe Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 75. Europe Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 76. Asia-Pacific Heparin (Low Molecular Weight) Sales by Region (2016-2021e) & (Kiloton)
Table 77. Asia-Pacific Heparin (Low Molecular Weight) Sales by Region (2021-2026) & (Kiloton)
Table 78. Asia-Pacific Heparin (Low Molecular Weight) Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Heparin (Low Molecular Weight) Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 81. Asia-Pacific Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 82. Asia-Pacific Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 83. Asia-Pacific Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 84. South America Heparin (Low Molecular Weight) Sales by Country (2016-2021e) & (Kiloton)
Table 85. South America Heparin (Low Molecular Weight) Sales by Country (2021-2026) & (Kiloton)
Table 86. South America Heparin (Low Molecular Weight) Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Heparin (Low Molecular Weight) Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 89. South America Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 90. South America Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 91. South America Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 92. Middle East & Africa Heparin (Low Molecular Weight) Sales by Country (2016-2021e) & (Kiloton)
Table 93. Middle East & Africa Heparin (Low Molecular Weight) Sales by Country (2021-2026) & (Kiloton)
Table 94. Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Heparin (Low Molecular Weight) Sales by Type (2016-2021e) & (Kiloton)
Table 97. Middle East & Africa Heparin (Low Molecular Weight) Sales by Type (2021-2026) & (Kiloton)
Table 98. Middle East & Africa Heparin (Low Molecular Weight) Sales by Application (2016-2021e) & (Kiloton)
Table 99. Middle East & Africa Heparin (Low Molecular Weight) Sales by Application (2021-2026) & (Kiloton)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Heparin (Low Molecular Weight) Typical Distributors
Table 103. Heparin (Low Molecular Weight) Typical Customers
List of Figures
Figure 1. Heparin (Low Molecular Weight) Picture
Figure 2. Global Heparin (Low Molecular Weight) Sales Market Share by Type in 2020
Figure 3. Enoxaparin
Figure 4. Dalteparin
Figure 5. Tinzaparin
Figure 6. Fraxiparine
Figure 7. Global Heparin (Low Molecular Weight) Sales Market Share by Application in 2020
Figure 8. Treatment of Venous Thromboembolism
Figure 9. Complications of Pregnancy
Figure 10. Cardioversion of Atrial Fibrillation/Flutter
Figure 11. Others
Figure 12. Global Heparin (Low Molecular Weight) Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 13. Global Heparin (Low Molecular Weight) Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Heparin (Low Molecular Weight) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Heparin (Low Molecular Weight) Sales (2016-2026) & (Kiloton)
Figure 34. Global Heparin (Low Molecular Weight) Production Capacity (2016-2026) & (Kiloton)
Figure 35. Global Heparin (Low Molecular Weight) Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Heparin (Low Molecular Weight) Market Drivers
Figure 37. Heparin (Low Molecular Weight) Market Restraints
Figure 38. Heparin (Low Molecular Weight) Market Trends
Figure 39. Global Heparin (Low Molecular Weight) Sales Market Share by Manufacturer in 2020
Figure 40. Global Heparin (Low Molecular Weight) Revenue Market Share by Manufacturer in 2020
Figure 41. Heparin (Low Molecular Weight) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Heparin (Low Molecular Weight) Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Heparin (Low Molecular Weight) Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Heparin (Low Molecular Weight) Sales Market Share by Region (2016-2026)
Figure 45. Global Heparin (Low Molecular Weight) Revenue Market Share by Region (2016-2026)
Figure 46. North America Heparin (Low Molecular Weight) Revenue (2016-2026) & (USD Million)
Figure 47. Europe Heparin (Low Molecular Weight) Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Heparin (Low Molecular Weight) Revenue (2016-2026) & (USD Million)
Figure 49. South America Heparin (Low Molecular Weight) Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Heparin (Low Molecular Weight) Revenue (2016-2026) & (USD Million)
Figure 51. Global Heparin (Low Molecular Weight) Sales Market Share by Type (2016-2026)
Figure 52. Global Heparin (Low Molecular Weight) Revenue Market Share by Type (2016-2026)
Figure 53. Global Heparin (Low Molecular Weight) Price by Type (2016-2026) & (US$/Ton)
Figure 54. Global Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 55. Global Heparin (Low Molecular Weight) Revenue Market Share by Application (2016-2026)
Figure 56. Global Heparin (Low Molecular Weight) Price by Application (2016-2026) & (US$/Ton)
Figure 57. North America Heparin (Low Molecular Weight) Sales Market Share by Country (2016-2026)
Figure 58. North America Heparin (Low Molecular Weight) Revenue Market Share by Country (2016-2026)
Figure 59. North America Heparin (Low Molecular Weight) Sales Market Share by Type (2016-2026)
Figure 60. North America Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 61. Europe Heparin (Low Molecular Weight) Sales Market Share by Country (2016-2026)
Figure 62. Europe Heparin (Low Molecular Weight) Revenue Market Share by Country (2016-2026)
Figure 63. Europe Heparin (Low Molecular Weight) Sales Market Share by Type (2016-2026)
Figure 64. Europe Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Heparin (Low Molecular Weight) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Heparin (Low Molecular Weight) Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Heparin (Low Molecular Weight) Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 69. South America Heparin (Low Molecular Weight) Sales Market Share by Country (2016-2026)
Figure 70. South America Heparin (Low Molecular Weight) Revenue Market Share by Country (2016-2026)
Figure 71. South America Heparin (Low Molecular Weight) Sales Market Share by Type (2016-2026)
Figure 72. South America Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Heparin (Low Molecular Weight) Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Heparin (Low Molecular Weight) Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Heparin (Low Molecular Weight) Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Heparin (Low Molecular Weight) Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の低分子量ヘパリン（LMWH）市場 2021：企業別、地域別、種類・用途別 The Low Molecular Weight Heparin (LMWHs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界の分子量マーカー市場規模・現状・予測（2021年-2027年） Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and…
- 世界の低分子量ポリイソブチレン（LMPIB）市場 2021：企業別、地域別、種類・用途別 The Low Molecular Weight Polyisobutylene (LMPIB) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の医療用超高分子量ポリエチレン（UHMWPE）市場 2021：企業別、地域別、種類・用途別 The Medical Grade Ultra-High Molecular Weight Polyethylene (UHMWPE) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…
- 世界の分子量アナライザー市場 2021：企業別、地域別、種類・用途別 The Molecular Weight Analyzer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…